Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: J Pediatr Hematol Oncol. 2015 Jan;37(1):e13–e18. doi: 10.1097/MPH.0000000000000186

Table 2. Dose Levels and Dose-limiting Toxicity.

Dose Level Oxaliplatin mg/m2(day 1) Ifosfamide mg/m2/day (days 1,2,3) Etoposide mg/m2/day (days 1,2,3) No. of patients (No. evaluable) DLT (No. of patients)
1 130 1,500 75 4 (3) Neutropenia (2)
0 130 1,200 75 6 (6) Neutropenia (1)
0+filgrastim 130 1,200 75 4 (3) None
1+filgrastim 130 1,500 75 3 (3) None
2+filgrastim 130 1,500 100 2 (2) None

Abbreviation: DLT, dose-limiting toxicity